CymitQuimica logo

MyoMed 205

CAS:

Ref. TM-T88288

25mg
1,369.00€
50mg
1,783.00€
100mg
2,250.00€
MyoMed 205
Targetmol

Product Information

Name:MyoMed 205
Brand:Targetmol
Description:MyoMed-205 is an inhibitor of MuRF1 (muscle ring finger protein 1) activity. It effectively prevents early diaphragm contractile dysfunction and atrophy following 12 hours of unilateral phrenic nerve denervation. By inhibiting MuRF1, MyoMed-205 reduces muscle protein ubiquitination and subsequent proteasome degradation. It also increases the protein levels of phosphorylated Akt (ser473), an essential signaling molecule for muscle growth and maintenance. MyoMed-205 is applicable in the research and treatment of diaphragm dysfunction and atrophy (DIDD) due to early disuse, particularly in clinical situations such as diaphragm paralysis or mechanical ventilation.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:491.56
Formula:C26H25N3O5S
Color/Form:Solid

Technical inquiry about: MyoMed 205

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please add the desired products to your cart and manage the request from there. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.